News

Pharmabiz2h
AusperBio gets China CDE clearance to initiate phase III clinical trial of AHB-137 for chronic hepatitis B
AusperBio gets China CDE clearance to initiate phase III clinical trial of AHB-137 for chronic hepatitis B: San Francisco Wednesday, July 23, 2025, 18:00 Hrs [IST] AusperBio Thera ...
Pharmabiz4h
Medical Parliamentarians call for urgent action against growing burden of stroke
The Indian Medical Parliamentarians Forum (IMPF), a cross-party platform of medical professionals in the Parliament, has called for comprehensive and urgent action to address the growing burden of ...
Pharmabiz4h
Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL
Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...
Pharmabiz4h
Dr Rajesh Venkat Indala, Apollo Hospitals, Vizag neurologist honoured as Fellow of the American Academy of Neurology
Dr Rajesh Venkat Indala, Apollo Hospitals, Vizag neurologist honoured as Fellow of the American Academy of Neurology: Our Bureau, Mumbai Wednesday, July 23, 2025, 15:45 Hrs [IST] ...
Pharmabiz5h
Biocon Biologics appoints Deepali Naair as global head - brand & corporate communications
Biocon Biologics appoints Deepali Naair as global head - brand & corporate communications: Our Bureau, Bengaluru Wednesday, July 23, 2025, 15:15 Hrs [IST] Biocon Biologics has app ...
Pharmabiz6h
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer
US FDA grants fast track designation to DualityBio's next-generation HER3 ADC DB-1310 to treat nonsquamous non-small cell lung cancer: Shanghai Wednesday, July 23, 2025, 14:30 Hrs ...
Pharmabiz6h
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery
Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus surgery: South San Francisco Wednesday, July 23, 2025, ...
Pharmabiz7h
Centre screens six crore individuals for sickle cell disease
The Central government has said that it has conducted screening of a total of six crore individuals for sickle cell disease (SCD) against the targeted seven crore under the National Sickle Cell ...
Pharmabiz7h
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line
WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...
Pharmabiz8h
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...
Pharmabiz10h
Weisheng & Nandani Medical Laboratories collaborate to advance intelligent pharma quality in India
Weisheng & Nandani Medical Laboratories collaborate to advance intelligent pharma quality in India: Our Bureau, Mumbai ...
Pharmabiz12h
MDC rejects Sun Pharma's application seeking separate ceiling price for antibiotic oral suspension
MDC rejects Sun Pharma's application seeking separate ceiling price for antibiotic oral suspension: Gireesh Babu, New Delhi Wednesday, July 23, 2025, 08:00 Hrs [IST] The Multidisc ...